Archives
-
CRISPR Repair Outcomes in Nondividing Human Cells
2026-10-07
A 2025 Nature Communications study shows that postmitotic human neurons repair Cas9-induced DNA damage differently from genetically matched dividing cells, with slower resolution and greater involvement of non-canonical repair factors. The findings establish cell state as a major determinant of genome-editing outcomes and suggest that repair responses can be studied, rather than treated as a fixed background variable, in clinically relevant cell types.
-
Vernakalant Hydrochloride: Evidence and Research Context
2026-10-06
Vernakalant Hydrochloride, also known as RSD1235, is an atrial-selective multi-ion-channel antiarrhythmic investigated for rapid conversion of recent-onset atrial fibrillation. Clinical evidence supports fast conversion in selected adults, while mechanistic selectivity, safety generalizability, long-term outcomes, and comparisons with alternative atrial fibrillation treatment strategies remain important research questions.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-10-06
Breen and colleagues developed a genetically drug-sensitized yeast platform that increases the ability to detect TOR pathway inhibitors, including marked sensitivity gains for Torin1 and GSK2126458. The study provides a useful early-stage discovery framework, while its growth-based readout remains a proxy that requires orthogonal validation in biochemical and mammalian systems.
-
Quercetin, PCSK9/LDLR, and Gestational Diabetes
2026-10-05
Hong et al. investigate whether quercetin can improve glucose and lipid disturbances in gestational diabetes mellitus through the PCSK9/LDLR axis and PI3K/AKT/GSK3β signaling. The study combines a high-fat-diet mouse model, a hepatocyte-based cellular model, and molecular docking, providing mechanistic evidence while leaving important questions about human translation and direct target engagement unresolved.
-
Brain-to-Spinal Circuits in Mechanical Allodynia
2026-10-05
Huo et al. identify a contralateral lateral parabrachial–hypothalamic–spinal pathway that influences both the laterality and persistence of mechanical allodynia in mice. The study links lPBN Oprm1 neurons, dmH Pdyn neurons, spinal dynorphin signaling, and κ-opioid receptors, providing a circuit-level framework for understanding why pain hypersensitivity can become bilateral or prolonged.
-
Phillygenin in Diabetic Nephropathy: Pathway Evidence
2026-10-04
A 2025 Phytomedicine study links phillygenin with reduced inflammation, apoptosis, and renal injury in cellular and db/db mouse models of diabetic nephropathy. Its main contribution is a coherent, but still preclinical, mechanism involving TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling.
-
Stattic as a Causal Probe of STAT3 Signaling
2026-10-03
Stattic is a small-molecule STAT3 inhibitor widely used to examine signaling, survival, and treatment response in cancer models. This article frames the compound as a causal research probe and connects HNSCC evidence with new mechanistic insights from the STING–STAT3–autophagy axis in psoriasis.
-
LIRP Enables Light-Controlled Gene Therapy
2026-10-02
A 2026 Trends in Biotechnology study introduces a rationally designed light-inducible RNA-releasing protein that controls mammalian translation by retaining regulatory RNA in darkness and releasing it under blue or ambient light. In mouse models, the system enabled light-responsive metabolic therapy and reversible control of retinal VEGF inhibition, illustrating how translation-level optogenetics could improve temporal control and safety in gene therapy.
-
Annexin V-Cy5 Apoptosis Detection Guide
2026-10-01
The Annexin V-Cy5 Apoptosis Kit supports rapid Annexin V apoptosis detection by labeling phosphatidylserine exposed on apoptotic-cell surfaces. Its one-step, 10-minute workflow is compatible with flow cytometry and fluorescence microscopy, but PS exposure should be interpreted alongside lysosomal and viability measurements.
-
Go 6983 for PKC Signaling Workflows
2026-10-01
Go 6983 offers a reversible way to test whether PKC activity contributes to neuronal hyperexcitability, cancer-associated signaling, or epithelial plasticity. This workflow-centered guide combines concentration planning, orthogonal readouts, and troubleshooting for more interpretable pan-PKC experiments.
-
Mestranol and Reversible Lysosomal Stress in Microglia
2026-09-30
A 2026 zebrafish study identifies mestranol as an inducer of a reversible lysosomal storage–like state in microglia, marked by cargo accumulation, impaired intracellular digestion, and immune transcriptional suppression without increased neuronal apoptosis. The work provides a live in vivo model for investigating acquired microglial lysosomal stress and for separating lysosomal dysfunction from cell-death phenotypes.
-
DrPISA Expands Thermal Proteomics into Aggregates
2026-09-30
The DrPISA study introduces a deep eutectic solvent-assisted reverse PISA workflow that makes heat-aggregated proteins accessible to quantitative mass spectrometry. Its DES-48 solubilization chemistry and streamlined six-temperature design improve proteome coverage, reveal subtle stability changes, and identify previously under-recognized drug–protein interactions such as the celastrol-associated signal involving LULL1.
-
Phosphatase Inhibitor Cocktail 3: Workflow Guide
2026-09-29
Protect phosphorylation-dependent signals from cell and tissue lysis through Western blotting, co-immunoprecipitation, and phosphoprotein analysis. This workflow guide shows how a 100X DMSO formulation supports reproducible signaling studies while avoiding inhibitor carryover and sample-handling errors.
-
EdU Cell Proliferation Kit for RA S-Phase Studies
2026-09-29
The EdU Cell Proliferation Kit converts DNA synthesis into a sensitive, non-radioactive TMB signal for studying rheumatoid arthritis fibroblast-like synoviocytes, drug responses, and genotoxic stress. This practical guide connects ARL4C-driven synoviocyte biology with a controlled 5-ethynyl-2'-deoxyuridine proliferation assay, including workflow design and troubleshooting.
-
iRGD-RBCM Nanocarriers Improve Neuroblastoma PDT
2026-09-28
A 2026 Journal of Materials Science study developed iRGD-functionalized red blood cell membrane vesicles for TPOR delivery in neuroblastoma photodynamic therapy. The biomimetic carrier improved cellular uptake, apoptosis-associated activity, migration inhibition, and tumor growth control compared with free photosensitizer, while also highlighting important translational limitations.